Anticytomegalovirus Peptides Point to New Insights for CMV Entry Mechanisms and the Limitations of In Vitro Screenings

There Is Always Another Way! Cytomegalovirus’ Multifaceted Dissemination Schemes

(2018) Joseph Jackson et al.   Viruses-Basel

Impact of Antibodies and Strain Polymorphisms on Cytomegalovirus Entry and Spread in Fibroblasts and Epithelial Cells

(2017) Xiaohong Cui et al.   JOURNAL OF VIROLOGY

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

(2017) Francisco M. Marty et al.   NEW ENGLAND JOURNAL OF MEDICINE

Current Peptide and Protein Candidates Challenging HIV Therapy beyond the Vaccine Era

(2017) Koollawat Chupradit et al.   Viruses-Basel

Dual-Energy SPECT and the Development of Peptide p5+14 for Imaging Amyloidosis

(2017) Jonathan S. Wall et al.   Molecular Imaging

Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors

(2017) Maria Carmina Scala et al.   Scientific Reports

The D-form of a novel heparan binding peptide decreases cytomegalovirus infection in vivo and in vitro

(2016) Elisabeth A. Pitt et al.   ANTIVIRAL RESEARCH

A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses

(2016) Hanjun Zhao et al.   Scientific Reports

A Role for 3-O-Sulfated Heparan Sulfate in Promoting Human Cytomegalovirus Infection in Human Iris Cells

(2015) John Baldwin et al.   JOURNAL OF VIROLOGY

Novel Heparan Sulfate-Binding Peptides for Blocking Herpesvirus Entry

(2015) Pranay Dogra et al.   PLoS One

Fields Virology, 6th Edition

(2014) L. Liu   CLINICAL INFECTIOUS DISEASES

A Peptide Inhibitor of Cytomegalovirus Infection from Human Hemofiltrate

(2013) Eva Maria Borst et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Peptide p5 binds both heparinase-sensitive glycosaminoglycans and fibrils in patient-derived AL amyloid extracts

(2013) Emily B. Martin et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Cytomegalovirus in the Neonate: Immune Correlates of Infection and Protection

(2013) Mark R. Schleiss   Clinical & Developmental Immunology

The “Silent” Global Burden of Congenital Cytomegalovirus

(2013) Sheetal Manicklal et al.   CLINICAL MICROBIOLOGY REVIEWS

Desirability and feasibility of a vaccine against cytomegalovirus

(2013) Paul Griffiths et al.   VACCINE

The Viral Chemokine MCK-2 of Murine Cytomegalovirus Promotes Infection as Part of a gH/gL/MCK-2 Complex

(2013) Felicia M. Wagner et al.   PLoS Pathogens

Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides

(2013) Kelly C. L. Mulder et al.   Frontiers in Microbiology

In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides

(2011) J. S. Wall et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Heparan Sulfate Proteoglycans

(2011) S. Sarrazin et al.   Cold Spring Harbor Perspectives in Biology

Antiviral Drug Resistance of Human Cytomegalovirus

(2010) N. S. Lurain et al.   CLINICAL MICROBIOLOGY REVIEWS

Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell culture

(2010) D. J. Dargan et al.   JOURNAL OF GENERAL VIROLOGY

I-TASSER: a unified platform for automated protein structure and function prediction

(2010) Ambrish Roy et al.   Nature Protocols

Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies

(2009) L. Nassetta et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

I-TASSER server for protein 3D structure prediction

(2008) Yang Zhang   BMC BIOINFORMATICS